Geneva, Oct. 27 -- International Clinical Trials Registry received information related to the study (ISRCTN14538094) titled 'Safety, tolerability, and pharmacokinetics of fatty acids' on Oct. 16.
Study Type: Interventional
Study Design:
Allocation: Non-randomized controlled trial
Masking: Open (masking not used)
Control: Active
Assignment: Parallel
Purpose: Absorption and tolerability study
Primary Sponsor: RDC Global
Condition:
Evaluating absorption and tolerability of investigational formulations in healthy volunteers
Other
Intervention:
In Part 1 participants will receive a single dose of one of the below investigational products, there will be 8 participants assigned to each group:
Group 1: 2.5g of natural fatty acid mixture ...